Skip to content

Intercil®

by Ciliatech

Ref INTERCILModel Intraocular Implant

Active European Union

CE MDR

Valid until

29 Jul 2030

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

2 certificates

Certifier KIWA CERMET ITALIA S.P.A.

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberMDR 00170-B Date9 Dec 2025IssuedStatusActive expires 29 Jul 2030

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • MDR 00170-A Active

    Quality management system EU MDR

    Issued
    5 Dec 2025
    Expires
    29 Jul 2030
  • MDR 00170-B Active

    Technical documentation EU MDR

    Issued
    9 Dec 2025
    Expires
    29 Jul 2030

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Model / Reference
Intraocular Implant, INTERCIL
Primary DI / UDI-DI
03770031733006
Basic UDI-DI
3770031733INTERCILVZ
EMDN Code
Q0299 Ophthalmic devices - other
Device Class
Class IIb
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
FR-MF-000035866

Properties

  • Sterile
  • Implantable

Other properties (12)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Sutures: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No